Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
LILite Strategy, Inc. logo

Lite Strategy, Inc. (LITS)

NASDAQ Capital Market · Currency in USD
$1.16 ▼ -0.03 (-2.52%)
At close: Oct 23, 4:00 PM ET. Market closed.
$1.16 ▲ +0.00 (+0.00%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$1.19
Open
$1.19
Day's Range
$1.16 – $1.20
52 Week Range
$0.69 – $2.26
Volume
141,127
Avg. Volume
407,753
Market Cap
$35.27M
Beta (5Y Monthly)
0.04
PE Ratio (TTM)
--
EPS (TTM)
-$2.06
Earnings Date
Nov 13, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
Nov 16, 2023
1y Target Est
--

Profile: Lite Strategy, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
5
CEO
Justin J. File

Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.

Earnings

Next report: Fri, Nov 13, 2026
EPS estimate -$3.12 · Revenue est. $5.41M
DateEst.Actual
Sep 28, 2026-$3.12-$0.38Beat
Feb 17, 2026-$3.12-$0.82Beat
Nov 14, 2025–-$0.12
Sep 29, 2025-$1.41-$2.76Miss
May 13, 2025–-$0.39
Feb 12, 2025-$2.20-$0.40Beat

Get free alerts on LITS and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.